Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study.
about
Jupiter to earth: a statin helps people with normal LDL-C and high hs-CRP, but what does it mean?Lipoprotein-associated oxidative stress: a new twist to the postprandial hypothesisCurrent therapies for lowering lipoprotein (a)Understanding the role of B cells in atherosclerosis: potential clinical implicationsB cell subsets in atherosclerosis.The role of oxidized phospholipids in atherosclerosis.Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate dietMipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: results of 4 phase III trials.Circulating autoantibodies against the apolipoprotein B-100 peptides p45 and p210 in relation to the occurrence of carotid plaques in 64-year-old women.Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk Study.Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events.Cardiac autonomic testing and treating heart disease. "A clinical perspective".Oxidized LDL and the metabolic syndromeIdeal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: The EPIC-Norfolk prospective population studyThe role of immune complexes in atherogenesis.Biomarkers of inflammation and oxidative stress in atherosclerosis.Cardiovascular Complications in CKD Patients: Role of Oxidative Stress.Role of phospholipid oxidation products in atherosclerosis.Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases.Experimental Animal Models Evaluating the Causal Role of Lipoprotein(a) in Atherosclerosis and Aortic Stenosis.Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis.Elaidate, an 18-carbon trans-monoenoic fatty acid, but not physiological fatty acids increases intracellular Zn(2+) in human macrophages.Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formationReduction of cardiovascular risk in subjects with high lipoprotein (a) levels.Elaidate, an 18-carbon trans-monoenoic fatty acid, inhibits β-oxidation in human peripheral blood macrophages.Simvastatin-induced changes in circulating oxidized low-density lipoprotein in different types of dyslipidemia.Effects of simvastatin on circulating autoantibodies to oxidized LDL antigens: relation with immune stimulation markers.
P2860
Q24630160-DBF0F4BA-55BD-4C41-956F-FA05F9DA7D7FQ26828643-A326DB03-CC6E-4320-8A97-A459A0088A17Q26830297-3E0A7F98-EA4F-4C9B-A342-67446ADB4582Q26991813-2838E7CA-C4B2-4F8F-9216-B71790CBC31BQ30423324-65A5BC3A-7F0E-4E5B-9E69-0369D8FCD075Q30436606-78068F8A-A83C-4BF9-96C6-A8A22401663BQ34188087-4F9FC2A1-3283-4A38-9DAC-CDAAABF73A15Q35130714-DA6FA337-81DB-49A6-9EB9-6EF1914C925FQ35175305-3CF01338-2A90-4C50-A223-1B51DD84F28EQ35212898-A8C3AEE9-DC79-44F7-9C89-E632CD6EADD9Q35592510-EFCA1877-F716-436B-BC89-82740A43AF80Q36641707-74540184-1735-48E1-BC94-71C00061A30CQ37074685-2EA6A577-5AB3-4E80-A0EE-DEECB212DDC3Q37660722-272EF28D-4ACD-4FAB-A6BB-3310B9F45137Q37731718-0C01A707-DB09-4024-BAE3-277D8FD4DDD8Q37765284-C76D31D2-84F6-493B-B8C0-DBDEF9318C00Q37831154-269A6F13-A2FC-40EB-909A-910C1C8A1DA7Q38039282-4ED5FBF5-970F-48C4-A717-31A1D8B29741Q38299279-99E5B1BE-E659-4E5C-94CF-3A63FFAB12A2Q38701405-B9D24A06-EDCD-44DB-A697-193578A95C10Q38839978-D6721736-642D-4662-8764-C220E27D8EB5Q41501038-2AB35C1A-08C9-45E9-BF23-F32A43AAF86DQ41898952-55E6734A-D5C1-4FD4-B111-2CE28E0E454CQ42357350-71A98801-3BA9-422C-A401-90361BEDE319Q42611560-A9D2D5F3-1530-4561-B20D-AA0FCD4CE50DQ42949809-7033218D-39A0-4304-A497-BC31AC91C127Q46081322-569EB39D-D26E-4330-9A43-CB697CD9CE14
P2860
Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Relationship between biomarker ...... ressive Lipid Lowering) study.
@en
Relationship between biomarker ...... ressive Lipid Lowering) study.
@nl
type
label
Relationship between biomarker ...... ressive Lipid Lowering) study.
@en
Relationship between biomarker ...... ressive Lipid Lowering) study.
@nl
prefLabel
Relationship between biomarker ...... ressive Lipid Lowering) study.
@en
Relationship between biomarker ...... ressive Lipid Lowering) study.
@nl
P2093
P50
P921
P1476
Relationship between biomarker ...... ressive Lipid Lowering) study.
@en
P2093
Andrew Chae
Anthony N DeMaria
Elizabeth Miller
Fady Ntanios
Michael Messig
Steven E Nissen
P356
10.1016/J.JACC.2008.02.066
P407
P577
2008-07-01T00:00:00Z